Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2026-06-29 21:30:06 ET · period of report 2026-06-25 · accession 0001593087-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-29 21:30 | 2026-06-25 | CAPR | Bergmann Anthony | CFO | M - OptEx | $3.18 | +24.1K | 35.3K | +215% | +$76.6K |
| D | 2026-06-29 21:30 | 2026-06-25 | CAPR | Bergmann Anthony | CFO | S - Sale+OE | $30.38 | -24.1K | 11.2K | -68% | -$732.2K |
| D | 2026-06-29 21:30 | 2026-06-25 | CAPR | Bergmann Anthony | CFO | M - OptEx | $0.00 | -24.1K | 92.0K | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-25 | M | A | 24,100 | $3.18 | 35,323 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-25 | S | D | 24,100 | $30.38 | 11,223 | D | — | — | (F1) Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. (F2) The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.88, inclusive. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-06-25 | M | D | 24,100 | $0.00 | 91,980 | D | $3.18 · — to 2032-01-03 | 24,100 Common Stock | (F3) Shares vested 1/48th on the first day of each month commencing February 1, 2022. |